Sean Silcoff
Verified
As seen in:
The Globe and Mail,
LinkedIn,
The New York Times,
The Current With Matt Galloway,
The Wall Street Journal,
Barnes and Noble,
Globe and Mail Breaking News Newsletter,
MarketWatch,
Report on Business Magazine,
The Decibel,
Flipboard
and
Covers:
technology, biotechnology, innovation policy, entrepreneurship
Storyteller. Newshound. Co-wrote Losing the Signal, about BlackBerry. I cover Canadian tech/biotech/innovation for Globe & Mail. Verified.
Sean Silcoff’s Journalist Portfolio
View as a list
Zymeworks wanted to be Canada's first Big Pharma. Despite two blockbusters-in-the-making, that's ...
Canada had - and lost - its lead in AI. Can it avoid making the same mistake in the next emerging...
Canadian CEOs are embracing generative AI's speed and efficiency. The impact on their employees i...
Welcome to the $100-million club: With dozens of scaled-up tech companies, Canada is poised to de...